Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/29/2010EP2266541A1 Solid pharmaceutical composition comprising rivaroxaban
12/29/2010EP2266540A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor
12/29/2010EP2266539A2 Methods of treatment using a gastric retained gabapentin dosage
12/29/2010EP2266537A2 Compositions and methods for treating cancer
12/29/2010EP2266536A2 Method of treating acute myocardial infarction
12/29/2010EP2266530A1 Oxazolidinones for cosmetic cutaneous use
12/29/2010EP2266525A1 High quality lipids and methods for producing by enzymatic liberation from biomass
12/29/2010EP2266500A2 Three-dimensional tissue structure
12/29/2010EP2266422A1 Synergism of GOS and polyfructose
12/29/2010EP2265725A1 Method for preparing ortho-dihydroxyisoflavones using a biotransformation system
12/29/2010EP2265645A2 Enzymatic substrates for multiple detection systems
12/29/2010EP2265629A2 Bismethylene-17 carbolactones and related uses
12/29/2010EP2265626A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use
12/29/2010EP2265623A1 Mitochondrially delivered anti-cancer compounds
12/29/2010EP2265620A1 Spiro derivatives of parthenin as novel anticancer agents
12/29/2010EP2265618A2 Aurora kinase inhibitors
12/29/2010EP2265616A1 Furo-and thieno[3,2-c]pyridines
12/29/2010EP2265615A1 Imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators
12/29/2010EP2265614A1 Imidazo [1,2-b]pyridazine derivatives for the treatment of c-met tyrosine kinase mediated disease
12/29/2010EP2265613A1 Quinazoline linked pyrrolo[2,1-c][1, 4]benzodiazepine hybrids as potential anticancer agents and process for the preparation thereof
12/29/2010EP2265612A1 Substituted xanthine derivatives
12/29/2010EP2265611A1 Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp)
12/29/2010EP2265610A1 Pyrazole [3, 4-b]pyridine raf inhibitors
12/29/2010EP2265609A1 Imdizo [4. 5-b] pyridine derivatives used as raf inhibitors
12/29/2010EP2265607A1 Pyrimidine-2-amine compounds and their use as inhibitors of jak kinases
12/29/2010EP2265606A1 Hepatitis c virus inhibitors
12/29/2010EP2265605A1 Dexlansoprazole process and polymorphs
12/29/2010EP2265602A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
12/29/2010EP2265601A1 Pyridazine derivatives as factor xia inhibitors
12/29/2010EP2265600A1 Pyridinyl amides for the treatment of cns and metabolic disorders
12/29/2010EP2265599A2 Crystal form of phenylamino pyrimidine derivative
12/29/2010EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/29/2010EP2265595A1 Novel flavonol compounds, a bioactive extract/fraction from ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders
12/29/2010EP2265594A2 Cysteine and cystine bioisosteres to treat schizophrenia and reduce drug cravings
12/29/2010EP2265593A1 Novel 1,2,4-triazole derivatives and process of manufacturing thereof
12/29/2010EP2265591A1 Nitrone compounds, process of preparation thereof, and use thereof in medicament manufacture
12/29/2010EP2265589A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
12/29/2010EP2265588A1 INHIBITORS OF 11ß -HYDROXYSTEROID DEHYDROGENASE TYPE 1
12/29/2010EP2265587A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
12/29/2010EP2265584A1 Hydroxyalkanyl amides as modulators of chemokine receptor activity
12/29/2010EP2265582A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof.
12/29/2010EP2265581A1 Compounds having crth2 antagonist activity
12/29/2010EP2265580A1 Novel method for the production of sulphonylpyrroles as hdac inhibitors
12/29/2010EP2265575A2 Sulfonamides
12/29/2010EP2265574A1 N- (6-aminopyridin-3-yl) -3- (sulfonamido) benzamide derivatives as b-raf inhibitors for the treatment of cancer
12/29/2010EP2265335A1 Indazole derivatives
12/29/2010EP2265334A2 Substituted xanthine derivatives
12/29/2010EP2265276A2 Compositions and methods for inhibiting expression of eg5 and vegf genes
12/29/2010EP2265275A2 Antiviral therapeutic agents
12/29/2010EP2265274A2 Methotrexate adjuvants to reduce toxicity and methods for using the same
12/29/2010EP2265273A1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
12/29/2010EP2265272A1 Adaptive biochemical signatures
12/29/2010EP2265271A1 Crystalline 2-(4-cyclopropanesulphonyl-phenyl)-n-pyrazin-2-yl-3-(tetrahydropyran-4-yl)-propionamide
12/29/2010EP2265270A1 2-aminopyridine kinase inhibitors
12/29/2010EP2265269A1 Selective subtype alpha 2 adrenergic agents and methods for use thereof
12/29/2010EP2265268A2 Stable fixed dose topical formulation
12/29/2010EP2265267A1 Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections
12/29/2010EP2265266A2 Vitamin d compounds and methods for reducing ocular hypertension (oht)
12/29/2010EP2265265A2 Treatment of inflammatory conditions and diseases with metal-thiols
12/29/2010EP2265264A1 Transdermal therapeutic system for administration of fentanyl or an analog thereof
12/29/2010EP2265263A2 Chewing composition and the use thereof
12/29/2010EP2265259A1 Rapidly disintegrating oral compositions of tramadol
12/29/2010EP2265258A2 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
12/29/2010EP2265257A2 Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
12/29/2010EP2265256A1 Dithiocarbamate metal chelates and methods of making and using thereof
12/29/2010EP2265255A1 Formulations of vitamin k analogs for topical use
12/29/2010EP2265253A2 Oral dosage form containing a pyridinol derivative
12/29/2010EP2265252A2 Ophthalmic preparation containing a pyridinol derivate
12/29/2010EP2265251A2 Pharmaceutical compositions having desirable bioavailability
12/29/2010EP2265249A1 Cosmetic compositions comprising exopolysaccharides derived from microbial mats, and use thereof
12/29/2010EP2265135A2 Synbiotic mixture
12/29/2010EP2265126A1 Methods and compositions for controlled delivery of phytochemical agents
12/29/2010EP2265125A1 Topical lfa-1 antagonists for use in localized treatment of immune related disorders
12/29/2010EP2265124A1 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
12/29/2010EP2265117A1 Inhibitors of protein phosphatase-1 and uses thereof
12/29/2010EP2265116A2 Steroidal ligands and their use in gene switch modulation
12/29/2010EP2265114A2 Use of epicatechin and derivatives and salts thereof for cardiac protection of ischemic myocardium and to ameliorate adverse cardiac remodeling
12/29/2010EP2185512B1 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
12/29/2010EP2175866B1 Novel one step process for preparing cross-linked poly(allylamine) polymers
12/29/2010EP2142527B1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/29/2010EP2131847B1 Drug comprising at least one gestagen
12/29/2010EP2104535B1 Compounds and compositions as channel activating protease inhibitors
12/29/2010EP2084175B1 Hcv nucleoside inhibitor
12/29/2010EP2084173B1 Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with fluorine, method for producing the same, drugs containing said compounds and use thereof
12/29/2010EP2069341B1 Pyrrolo[2, 3-b]pyridin-4-yl-benzenesulfonamide compounds as ikk2 inhibitors
12/29/2010EP2049546B1 Dihydrofuro pyrimidines as akt protein kinase inhibitors
12/29/2010EP2049519B9 Cyclic derivatives as modulators of chemokine receptor activity
12/29/2010EP2049091B1 Casein complexes
12/29/2010EP2044085B1 Penem prodrugs
12/29/2010EP1962836B1 Treatment of length dependent neuropathy
12/29/2010EP1951251B1 Spirohydantoin aryl cgrp receptor antagonists
12/29/2010EP1943243B1 Kinase inhibitors
12/29/2010EP1940826B1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
12/29/2010EP1933823B1 Pharmaceutical composition on basis of reverse transcriptase inhibitor and meldonium
12/29/2010EP1902712B1 Use of levo-ornidazole for preparing antiparasitic infection drug
12/29/2010EP1881985B1 Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide
12/29/2010EP1871768B1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/29/2010EP1861395B1 5-(1,3-diaryl-1h-pyrazol-4-ylmethylene)-thiazolidine-2,4-dione derivatives useful as anticancer agent
12/29/2010EP1861377B1 Benzimidazolone derivatives as cb2 receptor ligands
12/29/2010EP1857453B1 Fluoroalkylpyrrolidine derivatives
1 ... 1936 1937 1938 1939 1940 1941 1942 1943 1944 1945 1946 1947 1948 1949 1950 1951 1952 1953 1954 1955 1956 ... 7860